Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Burning Rock Biotech Limited BNR
$2.87
-$0 (-0.17%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
292623750.00000000
-
week52high
4.31
-
week52low
1.70
-
Revenue
563238000
-
P/E TTM
-2
-
Beta
0.16814100
-
EPS
-1.31000000
-
Last Dividend
0.00000000
-
Next Earnings Date
30 мая 2023 г. в 12:30
Описание компании
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. In addition, the company has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. It has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. The company was incorporated in 2014 and is headquartered in Guangzhou, China.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| CICC | Outperform | 14 июл 2021 г. | |
| B of A Securities | Buy | 13 июл 2020 г. | |
| Cowen & Co. | Outperform | 07 июл 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
21 ноя 2022 г. в 13:32
Burning Rock Biotech Limited Sponsored ADR (BNR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Burning Rock Biotech (BNR) Q3 2022 Earnings Call Transcript
Seeking Alpha
16 ноя 2022 г. в 11:41
Burning Rock Biotech Limited (NASDAQ:BNR ) Q3 2022 Earnings Conference Call November 16, 2022 8:30 AM ET Company Participants Yusheng Han - Chairman and CEO Dr. Shaokun Chuai - COO Leo Li - CFO Conference Call Participants Alexis Yan - Morgan Stanley Max Masucci - Cowen & Company Operator Good day and thank you for standing by. Welcome to the Burning Rock 2022 Third Quarter Earnings Conference Call.
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
GlobeNewsWire
25 окт 2022 г. в 00:46
GUANGZHOU, China, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it plans to release its unaudited financial results for the third quarter of 2022 before the U.S. market opens on November 16, 2022. Following the release, company management will host a conference call at 8:30 a.m. ET (9:30 p.m. Hong Kong time) on the same day to discuss its financial results for the third quarter of 2022.
Best Penny Stocks To Buy? 4 That Redditors Are Watching Now
PennyStocks
31 авг 2022 г. в 15:30
Penny stocks to buy according to Reddit sentiment. The post Best Penny Stocks To Buy?
Why Shares of Alibaba, JD.com, and Burning Rock Biotech Are Rising Today
The Motley Fool
31 авг 2022 г. в 13:24
Chinese stocks continue to benefit from a preliminary agreement between the U.S. and China on a long-standing auditing dispute.